BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14520484)

  • 1. High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level.
    Saitoh M; Osanai T; Kamada T; Matsunaga T; Ishizaka H; Hanada H; Okumura K
    Heart Vessels; 2003 Sep; 18(4):177-82. PubMed ID: 14520484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure.
    Usui M; Matsuoka H; Miyazaki H; Ueda S; Okuda S; Imaizumi T
    Life Sci; 1998; 62(26):2425-30. PubMed ID: 9651109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
    Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
    Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase.
    Yasuda S; Miyazaki S; Kanda M; Goto Y; Suzuki M; Harano Y; Nonogi H
    Eur Heart J; 2006 May; 27(10):1159-65. PubMed ID: 16627554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
    Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
    Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
    Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.
    Lluch P; Torondel B; Medina P; Segarra G; Del Olmo JA; Serra MA; Rodrigo JM
    J Hepatol; 2004 Jul; 41(1):55-9. PubMed ID: 15246208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
    Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay.
    Schulze F; Wesemann R; Schwedhelm E; Sydow K; Albsmeier J; Cooke JP; Böger RH
    Clin Chem Lab Med; 2004; 42(12):1377-83. PubMed ID: 15576299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects.
    Holven KB; Haugstad TS; Holm T; Aukrust P; Ose L; Nenseter MS
    Br J Nutr; 2003 Mar; 89(3):359-63. PubMed ID: 12628031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidation.
    Päivä H; Laakso J; Ruokonen I; Luomala M; Saarela M; Solakivi T; Metso S; Nikkilä M; Wuolijoki E; Laaksonen R; Lehtimäki T
    Clin Chim Acta; 2006 Sep; 371(1-2):97-101. PubMed ID: 16626676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
    Young JM; Strey CH; George PM; Florkowski CM; Sies CW; Frampton CM; Scott RS
    Eur J Heart Fail; 2008 May; 10(5):463-6. PubMed ID: 18430606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between serum asymmetric dimethylarginine and blood pressure in patients with chronic renal failure].
    Zhang WR; Tao LJ; Chen BM
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):133-4. PubMed ID: 12575339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.